Part 1. Discovery of a Fluorinated Enigmol Analog with Enhanced Pharmacokinetic and Anti-Tumor Properties. Part 2. Preferential Activation of Metabotropic Glutamate Receptor 3 over Metabotropic Glutamate Receptor 2
1 of 2
Regulation of Glutamate Transporter and Receptor Function by the
NHERF Scaffolding Proteins